购物车

全部删除
您的购物车当前为空

前往下单页继续购物

IL-8/CXCL8 Protein, Human, Recombinant (HEK293, His)

一键复制产品信息

产品编号 TMPY-04726U

IL-8/CXCL8 Protein, Human, Recombinant (HEK293, His) is expressed in HEK293 Cells. The accession number is P10145-1.

IL-8/CXCL8 Protein, Human, Recombinant (HEK293, His)

一键复制产品信息

产品编号 TMPY-04726U

IL-8/CXCL8 Protein, Human, Recombinant (HEK293, His) is expressed in HEK293 Cells. The accession number is P10145-1.

规格	价格	库存	数量

大包装 & 定制

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

实验操作小课堂

常见问题解答

资源下载

重组蛋白用户指南

产品信息

生物活性	Immobilized Human IL-8, His Tag at 0.5 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-IL-8 Antibody, hFc Tag with the EC50 of 12.5 ng/ml determined by ELISA.
产品描述	IL-8/CXCL8 Protein, Human, Recombinant (HEK293, His) is expressed in HEK293 Cells. The accession number is P10145-1.
种属	Human
表达系统	HEK293 Cells
标签	C-His
蛋白编号	P10145-1
别名	NAP-1,NAP1,NAF,MONAP,MDNCF,LYNAP,LUCT,LECT,Interleukin-8,IL-8,IL8,GCP-1,GCP1,chemokine (C-X-C motif) ligand 8
蛋白构建	Ser28-Ser99
蛋白纯度	> 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC
分子量	9.5 kDa (Predicted); 11-13 kDa (Due to glycosylation)
内毒素	< 1.0 EU/μg of the protein as determined by the LAL method.
蛋白性状	Lyophilized powder
缓冲液	Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
存储	Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
运输方式	In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice.
研究背景	Interleukin-8 (IL-8) has been revealed as a critical regulator of CNS function and development with participation in many CNS disorders including gliomas.Several promising approaches that target directly or indirectly IL-8 effects in gliomas are currently in progress while more-in-depth studies are needed to validate its biomarker role and elucidate the underlying molecular mechanisms.